Crohn's

News

Janssen J&J Johnson and Johnson pharmaceutical companies

Janssen trials ultrasound-guided approach to treating Crohn'...

In the highly competitive market for inflammatory diseases such as Crohn's, pharma companies are looking for ways to maximise benefits of already approved drugs, as well as

News

EU approval for Crohn's another boost for fast-growing Stela...

Janssen’s big-selling Stelara has been approved for second-line treatment of Crohn’s disease in the European Union.

News

AstraZeneca Amenities Building - Mississauga - Sept 2005
Non exclusive, unlimited time license for print & web to WZMH Architects

AZ sells potential Crohn's drug to Allergan

AstraZeneca is continuing its strategy of out-licensing drugs outside its core areas, selling off a mid-stage pipeline Crohn’s disease drug to Allergan in a deal potentially worth more than

News